Published in J Pharm Pharmacol on April 01, 1979
Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia (1975) 2.10
Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. Eur J Clin Pharmacol (1971) 1.72
Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev (1986) 1.61
Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther (1980) 1.43
The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites. Adv Pharmacol Chemother (1969) 1.29
Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. Mol Pharmacol (1981) 1.17
Thin-layer chromatographic and thin-layer electrophoretic analysis of ergot alkaloids. Relations between structure, RM value and electrophoretic mobility in the clavine series. Acta Pharm Suec (1965) 1.15
Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users. J Pharm Pharmacol (1988) 1.13
Binding of delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol (1970) 1.05
Gas chromatographic determination of ethosuximide and phensuximide in plasma and urine of man. J Pharm Pharmacol (1973) 1.01
Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin Pharmacol Ther (1972) 1.01
Kinetics of chlormethiazole in patients with alcohol withdrawal manifestations. Clin Pharmacol Ther (1978) 0.95
Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharmacol (1982) 0.95
Pentazocine binding to blood cells and plasma proteins. Clin Pharmacol Ther (1974) 0.94
Elimination of tritium-labelled cannabinols in the rat with special reference to the development of tests for the identification of cannabis users. Biochem Pharmacol (1969) 0.93
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology (Berl) (1981) 0.93
Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom (1986) 0.92
Fate and metabolism of some hallucinogenic indolealkylamines. Adv Pharmacol (1968) 0.91
Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana. Eur J Clin Pharmacol (1989) 0.90
Pharmacokinetics of clomethiazole in healthy adults. Acta Pharmacol Toxicol (Copenh) (1978) 0.90
Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia (1981) 0.90
Plasma kinetics of methaqualone in man after single oral doses. Eur J Clin Pharmacol (1973) 0.89
Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method. Scand J Clin Lab Invest (1972) 0.88
Alkaloids in certain species of Virola and other South American plants of ethnopharmacologic interest. Acta Chem Scand (1969) 0.87
Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol. Biochem Pharmacol (1974) 0.87
Metabolism of 5-methoxy-N,-N dimethyltryptamine- 14 C in the rat. Biochem Pharmacol (1969) 0.86
A complete biosynthetic sequence from tyrosine to mescaline in two cactus species. Tetrahedron Lett (1969) 0.86
The highly tumorigenic 3,4-dihydrodiol is a principal metabolite formed from dibenzo[a,h]anthracene by liver enzymes. Mol Pharmacol (1979) 0.86
Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Biomed Mass Spectrom (1982) 0.86
Cocaine in blood of coca chewers. J Ethnopharmacol (1979) 0.85
Disappearance from the newborn of circulating prenatally administered phenobarbital. Eur J Clin Pharmacol (1973) 0.85
Urinary metabolites of delta 1-tetrahydrocannabinol in man. Arzneimittelforschung (1982) 0.84
Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration. NIDA Res Monogr (1981) 0.82
Biosynthetic studies on ergot alkaloids and related indoles. Acta Pharm Suec (1966) 0.82
Biosynthesis of mescaline and tetrahydroisoquinoline alkaloids in Lophophora williamsii (Lem.) Coult. Acta Pharm Suec (1971) 0.81
Delta-1-tetrahydrocannabinol: structure of a major metabolite. Science (1970) 0.81
Plasma concentrations and effects of methaqualone after single and multiple oral doses in man. Eur J Clin Pharmacol (1974) 0.81
Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives. Acta Chem Scand (1968) 0.80
Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man. J Pharm Pharmacol (1974) 0.80
Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers. Drug Metab Dispos (1982) 0.80
Biosynthesis of ergot alkaloids. Origin of the side chain of ergometrine. Acta Chem Scand (1969) 0.80
Metabolism of pentachlorophenol. Arch Toxicol (1974) 0.80
Alkaloid content of Banisteriopsis rusbyana. Am J Pharm Sci Support Public Health (1969) 0.79
delta 1-Tetrahydrocannabinol and 1 alpha, 2 alpha-epoxyhexahydrocannabinol: mutagenicity investigation in the Ames test. Mutat Res (1979) 0.79
Synthesis and psychotropic activity of side-chain hydroxylated delta6-tetrahydrocannabinol metabolites. Acta Pharm Suec (1979) 0.79
Quantitation of phenobarbital and its main metabolites in human urine. Eur J Clin Pharmacol (1975) 0.79
Pressor response of oral tyramine in healthy men given amiflamine and placebo. Clin Pharmacol Ther (1986) 0.78
Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking. Acta Pharm Suec (1971) 0.78
Synthesis of a potential urinary tetrahydrocannabinol metabolite. Acta Pharm Suec (1972) 0.78
Quantitation of 1-tetrahydrocannabinol in plasma from cannabis smokers. J Pharm Pharmacol (1973) 0.78
Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats. J Pharmacol Exp Ther (1992) 0.77
Effects of 7-hydroxy-delta-6-tetrahydrocannabinol and some related cannabinoids on the guinea pig isolated ileum. Acta Physiol Scand (1975) 0.77
On the metabolism of tritium-labelled 1-tetrahydrocannabinol in the rabbit. Biochem Pharmacol (1970) 0.77
Total synthesis of cannabidiol and delta1-tetrahydrocannabinol metabolites. J Chem Soc Perkin 1 (1976) 0.77
Peyote alkaloids: identification in a prehistoric specimen of lophophora from coahuila, Mexico. Science (1978) 0.77
Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinol. Drug Metab Dispos (1979) 0.76
Identification of two new beta-carboline alkaloids in South American hallucinogenic plants. Biochem Pharmacol (1968) 0.76
Neutral in vivo metabolites of cannabinol isolated from rat faeces. J Pharm Pharmacol (1977) 0.76
Whole-body autoradiography of 1-tetrahydrocannabinol and 1(6)-tetrahydrocannabinol in mouse. Pharmacokinetic aspects of 1-tetrahydrocannabinol and its metabolites. Acta Pharm Suec (1973) 0.76
Delta 6-tetrahydrocannabinol-7-oic acid, a urinary delta 6-THC metabolite: isolation and synthesis. Experientia (1973) 0.76
Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat. Biochem Pharmacol (1974) 0.76
The research and development of a 5-HT selective reuptake blocker. Preclinical aspects. Acta Psychiatr Scand Suppl (1983) 0.76
Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking. Biomed Environ Mass Spectrom (1987) 0.76
Acidic in vivo metabolites of cannabinol isolated from rat faeces. J Pharm Pharmacol (1978) 0.76
Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism. J Pharm Pharmacol (1975) 0.76
Natural occurrence of 4-dimethylallyltryptophan-an ergot alkloid precursor. Tetrahedron Lett (1968) 0.76
In vivo metabolites of cannabinol identified as fatty acid conjugates. J Pharm Pharmacol (1978) 0.75
Biosynthesis of mescaline in peyote. Tetrahedron Lett (1967) 0.75
Biosynthesis of ergot alkaloids in Claviceps paspali. I. Incorporation of DL-4-dimethylallyltryptophan-14C. Acta Pharm Suec (1966) 0.75
Biosynthesis of ergot alkaloids in Claviceps paspali. II. Incorporation of labelled agroclavine, elymoclavine, lysergic acid and lysergic acid methyl ester. Acta Pharm Suec (1966) 0.75
Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine. Acta Pharm Suec (1966) 0.75
A biosynthetic sequence from tryptophan to psilocybin. Tetrahedron Lett (1968) 0.75
Biosynthesis of ergot alkaloids in Claviceps paspali. 3. Incorporation of 6-methyl-delta-8,9-ergolene-8-carboxylic acid-14C and lysergic acid-8-3H. Acta Pharm Suec (1966) 0.75
Biosynthesis of mescaline and anhalamine in peyote. IIa. Tetrahedron Lett (1968) 0.75
Distribution and elimination of 2-[14C]-acetone in mice after inhalation exposure. Scand J Work Environ Health (1982) 0.75
Isolysergol from saprophytic cultures of ergot. Acta Pharm Suec (1966) 0.75
Biosynthesis of ergot alkaloids in Claviceps paspali. IV. Incorporation experiments with lysergic acid amide-3H, isolysergic acid amide-3H and ethylamine-14C. Acta Pharm Suec (1966) 0.75
Thin-layer chromatography of the peyote alkaloids. J Chromatogr (1967) 0.75